Corporate Presentation Vaxart Investor Presentation - August 2024 Past Presentations Cantor Healthcare Conference September 2023 Vaxart Monovalent Norovirus Challenge Study Data Review Vaxart Norovirus KOL Presentation Potent Immune Responses to Norovirus G1.1 Evaluated in Elderly Subjects following Oral Tablet Delivery in a Phase 1 Placebo-Controlled Study – World Vaccine Congress 2022, Dr. James Cummings Oral Tablet Vaccination to SARS-CoV-2 Induces Long Lasting Crossreactive Mucosal Antibody Responses in Humans – World Vaccine Congress 2022, Dr. Sean Tucker Mucosal rAd5 Immunization Against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in Non-Human Primates, Dr. Becca Flitter Americans tell pollsters they want an oral vaccine Oral Tablet Vaccination to SARS-CoV-2 Induces Pan-coronavirus Nasal IgA Responses in Humans, Dr. Sean Tucker The Importance of T-cell Responses for COVID-19 Vaccines, Dr. Sean Tucker
Potent Immune Responses to Norovirus G1.1 Evaluated in Elderly Subjects following Oral Tablet Delivery in a Phase 1 Placebo-Controlled Study – World Vaccine Congress 2022, Dr. James Cummings
Oral Tablet Vaccination to SARS-CoV-2 Induces Long Lasting Crossreactive Mucosal Antibody Responses in Humans – World Vaccine Congress 2022, Dr. Sean Tucker
Mucosal rAd5 Immunization Against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in Non-Human Primates, Dr. Becca Flitter
Oral Tablet Vaccination to SARS-CoV-2 Induces Pan-coronavirus Nasal IgA Responses in Humans, Dr. Sean Tucker
